Filing Details
- Accession Number:
- 0001021561-11-000066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-17 20:06:05
- Reporting Period:
- 2011-05-16
- Filing Date:
- 2011-05-17
- Accepted Time:
- 2011-05-17 20:06:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1021561 | Nu Skin Enterprises Inc | NUS | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 870565309 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231132 | Matthew D Dorny | C/O Nu Skin Enterprises, Inc. 75 West Center Street Provo UT 84601 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2011-05-16 | 14,875 | $9.40 | 39,453 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2011-05-16 | 4,000 | $12.45 | 43,453 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2011-05-16 | 18,875 | $37.74 | 24,578 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2011-05-16 | 14,875 | $0.00 | 14,875 | $9.40 |
| Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2011-05-16 | 4,000 | $0.00 | 4,000 | $12.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 29,750 | 2010-02-27 | 2016-02-27 | No | 4 | M | Direct |
| 0 | 2012-04-19 | No | 4 | M | Direct |
Footnotes
- Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
- Becomes exercisable in four equal annual installments, the first of which becomes exercisable on the date indicated.
- Currently exercisable in full.
Billionaire Hedge Funds
